SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in IMDX — Insight Molecular Diagnostics Inc.
CIK 1446194
BALA CYNWYD, PA
Position in IMDX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$183,985
-$359,397 QoQ
Shares Held
56,093
-22.6% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMDX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $350,142,810 across 32 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
644,138 | $96,640,024 | |
| 2 | DHR |
Danaher Corp /De/
|
225,380 | $42,930,380 | |
| 3 | NTRA |
Natera, Inc.
|
133,758 | $36,308,609 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
69,202 | $34,695,114 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
54,439 | $28,658,866 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
82,213 | $15,885,195 | |
| 7 | ILMN |
Illumina, Inc.
|
67,131 | $11,803,643 | |
| 8 | GRAL |
GRAIL, Inc.
|
155,295 | $10,601,989 |
All Filings in IMDX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $183,985 | 56,093 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $543,382 | 72,451 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $35,620 | 11,795 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $137,106 | 44,806 | Shares | Other | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||